Jiangsu Hengrui Pharmaceuticals (01276) spent 19.9599 million yuan on January 30 to repurchase 343,100 A-shares.
Hengrui Medicine (01276) announced that on January 30, 2026, the company spent 1995.99 million yuan to repurchase 343,100 shares of A-shares at a repurchase price of 58.12-58.21 yuan per share.
Jiangsu Hengrui Pharmaceuticals (01276) announced that on January 30, 2026, the company will spend RMB 1995.99 million to repurchase 343,100 A shares at a repurchase price of RMB 58.12-58.21 per share.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
